Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-02

Clinical Trial Update: Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial evaluating the combination of metformin with high-dose dexamethasone in relapsed multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • metformin (metformin)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN